Adaptate Biotherapeutics

Developer of T-cell based immunotherapy for treating cancer

placeLondon, England, United Kingdom calendar_todayFounded 2019 groups21 employees language adaptate.com

Registered entities

Investor mix

1 investor on record; lead investors include Abingworth.

Investor typeCountShare
Venture capital1100%
Coming soon